For all IP practitioners, ranging from those that draft patent specifications, through in house lawyers and outside counsel, that deal with pharmaceuticals, this case is a ‘must read’. For ‘big pharma’ itself, it is a welcome relief following (then) Arnold J’s first instance judgement on how claims with functional and structural limitations should be considered when attacked on the basis of insufficiency, in particular, a lack of plausibility and undue burden.
In redressing the unduly high burden placed on patentees by Arnold J’s approach to insufficiency, Birss LJ has given substantial hope to the pharmaceutical industry, that claiming a broad category of chemical compounds, in and of itself, will not lead to invalidity issues. Nevertheless, his analysis of the law and reasoning need to be paid careful attention, in order to stay on the right side of the line for excessive breadth claims.READ MORE
Dehns is delighted to have successfully retained its Tier 1 ranking in the PATMA: Patent Attorneys category of the latest The Legal 500 rankings. Our Trade Mark Group also retained its ranking in the PATMA: Trade Mark category.READ MORE
Dehns, one of Europe’s leading firms of intellectual property specialists, has today announced the arrival of a new Partner, and Head of Litigation, Paul Harris.READ MORE
This award is based on nominations from Phil’s clients, and also IAM’s own in-depth global research to identify those “shown to possess world-class skills in the development and roll-out of strategies that maximise the value of patents, copyright, trademarks and other IP rights”.READ MORE
We are pleased to announce that Dehns Partner Thomas Kudlek has just been named as one of ‘Germany’s Best Lawyers’ in an exclusive ranking published by the Handelsblatt.READ MORE
Dehns has today announced its merger with Kudlek Grunert & Partner (KGP), a German firm of patent and trade mark attorneys with whom Dehns has enjoyed a close association for more than 20 years, and with whom there has been a formal joint venture, “Dehns Germany”, since 2013.READ MORE
We are delighted to announce that Dehns has recently acquired Leogriff, one of Norway’s leading Intellectual Property (IP) Consultancies.READ MORE
MyEnergi is a young and growing UK company designing and manufacturing renewable energy products for the home, such as the “zappi”, a multi-award winning eco-smart electric vehicle charger, and the “eddi”, a controller for solar power generation systems.view case study
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialisation of innovative specialty medicines for treating serious and chronic diseases, where there are clear medical needs and potential to significantly improve treatment.
Oxford Flow Ltd designs, manufactures and sells industrial pressure regulators using innovative technology to provide new levels of performance for natural gas transmission, water distribution, oil and gas, and process industries.view case study
airMont AS is a small Norwegian start-up that provides digital services directed to improving air quality. Dehns has worked with airMont since their inception, advising on matters relating to IP and innovation management.view case study
After many years of working with Dehns, a medium-sized Norwegian technology company requested a valuation of the entire IP portfolio to present to shareholders and to help inform decisions being made by the board.view case study
EQT required Dehns to carry out due diligence on AutoStore’s portfolio and address any issues surrounding the strength of the IP portfolio and Freedom to Operate over third party IP rights, as well as advising on a dispute involving UK online grocery retailer, Ocado.view case study
Getting to know us before we get to know you
We offer a stimulating working environment and as a progressive firm we want to invest in the brightest and most talented individuals from all walks of life. We value our people in every area of the business and pride ourselves on a collaborative and open approach across all offices.View careers
We are a leading European intellectual property firm, with more than 260 people across eight offices, and with an internationally renowned reputation.
Our CSR initiatives define who we are as a firm
They are a vital part of business, not only for our employees but our clients as well. We aim to involve every member of Dehns in our CSR programme to promote the core values and behaviours that underpin our identity.View CSR page